Melanotan 2 Injection Frequency Explained

Melanotan 2 injection frequency is not something a drug label specifies, because Melanotan 2 (MT-2) has no FDA-approved injectable label to specify it. That puts it in a different position from an FDA-approved peptide, where frequency is fixed by regulatory review. This reference explains what determines frequency in MT-2 research protocols instead, and — more usefully — how frequency interacts with the reconstitution math that decides how long a vial actually lasts. It is written for research and educational purposes only and is not medical advice.

No approved label sets a fixed frequency

Some research peptides carry an approved formulation with a specific labeled schedule; tesamorelin, for example, has an approved once-daily label for its narrow indication, indexed on DailyMed (NIH/NLM). Melanotan 2 does not have an equivalent approved injectable drug label. Without that regulatory anchor, there is no single "correct" Melanotan 2 injection frequency the way there is for a handful of approved peptides — only frequencies that show up across different research write-ups and protocols, which vary from source to source.

That absence of a fixed standard matches how MT-2 is treated elsewhere on this site: there's no single required water volume for reconstitution either, only reference concentrations chosen because they land typical research doses on clean unit marks — see the Melanotan 2 dosage chart. Frequency works the same way: a protocol detail set by whoever designed the specific research use, not a number handed down from an approved label.

What frequency actually controls

Frequency answers one question: how many times per period does a draw come out of the vial. It does not answer a separate question: what is the concentration of what's in the vial. That second question is fixed the moment bacteriostatic water is added:

Concentration = vial mass (mcg) ÷ water added (mL)

A vial reconstituted to a given concentration stays at that concentration through every draw, whether the schedule calls for one draw a day or one draw every few days. Frequency and concentration are independent variables that happen to combine into a third, more practical number: how many days a single vial will actually cover.

Worked example: vial life at two frequencies

Take a 10 mg Melanotan 2 vial reconstituted with 2 mL of bacteriostatic water, at a 250 mcg target dose per draw — the same reference setup used in the Melanotan 2 reconstitution calculator guide.

Step 1 — convert vial mass to mcg. 10 mg = 10,000 mcg (1 mg = 1,000 mcg).

Step 2 — concentration. 10,000 mcg ÷ 2 mL = 5,000 mcg/mL.

Step 3 — volume per dose. 250 mcg ÷ 5,000 mcg/mL = 0.05 mL.

Step 4 — syringe units. On a U-100 insulin syringe, 1 mL = 100 units, so 0.05 mL × 100 = 5 units per draw.

Step 5 — doses per vial. 10,000 mcg ÷ 250 mcg = 40 doses. This number depends only on vial mass and dose size — the water volume chosen in Step 2 doesn't change it.

Step 6 — vial life by frequency. At once daily, 40 doses run 40 days, or about 5.7 weeks. At every other day, the same 40 doses stretch to 40 × 2 = 80 days, or about 11.4 weeks. Neither frequency is presented here as a recommendation — they're two illustrative points showing how the same vial and dose produce very different vial-life numbers depending on how often it's drawn.

A 500 mcg dose from the same vial follows the identical formula at a faster draw-down. At 5,000 mcg/mL, 500 mcg is 0.1 mL, or 10 units. Doses per vial drop to 10,000 ÷ 500 = 20. At once daily that's 20 days (about 2.9 weeks); at every other day, 40 days (about 5.7 weeks).

Target dose	Concentration	Units per draw	Doses per vial	Vial life — once daily	Vial life — every other day
250 mcg	5,000 mcg/mL	5 units	40	40 days (~5.7 weeks)	80 days (~11.4 weeks)
500 mcg	5,000 mcg/mL	10 units	20	20 days (~2.9 weeks)	40 days (~5.7 weeks)

Frequency and dose size are separate decisions

It's easy to assume a higher Melanotan 2 injection frequency automatically means a smaller per-draw dose, since that pattern shows up in some protocols. The arithmetic doesn't require it. A protocol can hold the dose steady and simply draw from the vial more often — which draws the vial down faster and shortens vial life — or it can lower the dose to stretch the same vial across more frequent draws. Frequency, dose size, and vial life are three separate numbers connected by the doses-per-vial formula above; changing one doesn't automatically change another unless the protocol is designed that way.

Why research protocols on frequency disagree

Because there's no approved label to converge around, published and self-reported MT-2 protocols describe a range of schedules rather than one standard. Some describe daily draws; others space them out. This guide does not recommend a frequency or take a position on which protocol is better — that's a research design question outside the scope of a reconstitution reference, and outside what a peptide calculator can tell you. What the math above can tell you is how any given frequency plays out against a specific vial size, water volume, and dose once you've settled on one.

Keeping frequency and concentration from drifting apart

A frequency-based vial-life estimate is only accurate if the concentration behind it hasn't changed. Track the date a vial was reconstituted, not just when it was opened. If a vial that should supply 40 doses at 5,000 mcg/mL runs out sooner than the frequency and dose size predict, the concentration used in the original calculation is the more likely source of the mismatch, not the compound itself.

Common mistakes

• Looking for an official Melanotan 2 injection frequency. No approved label sets one — treat any specific number as a protocol detail, not a standard.
• Assuming frequency changes concentration. It doesn't. Concentration is fixed at reconstitution; frequency only affects how fast the vial's total mcg gets drawn down.
• Confusing mg and mcg when estimating vial life. MT-2 vials are labeled in milligrams, but doses are almost always described in micrograms — a 10 mg vial is 10,000 mcg, not 10.
• Reusing a vial-life estimate after changing the water volume or dose. The 40-day and 80-day figures above only hold at 5,000 mcg/mL and a 250 mcg dose. Change either input and the vial-life number changes with it.

Use the calculator

Enter your Melanotan 2 vial size, bacteriostatic water volume, and target dose into the peptide reconstitution calculator to get the exact concentration, draw volume, and syringe units, then apply your intended frequency to the doses-per-vial figure to estimate vial life. For the full mixing steps, see the Melanotan 2 reconstitution calculator guide; for how vial size and water volume interact across a range of doses, see the Melanotan 2 dosage chart.